![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 10
Zeitschriftenartikel
Tomsitz, Dirk 
ORCID: https://orcid.org/0000-0003-0036-072X; Livingstone, Elisabeth; Loquai, Carmen; Kaatz, Martin; Leiter, Ulrike ORCID: https://orcid.org/0000-0002-8019-1577; Schilling, Bastian ORCID: https://orcid.org/0000-0001-8859-4103; Terheyden, Patrick; Hassel, Jessica; Sachse, Michael; Ulrich, Jens; Dippel, Edgar; Meiss, Frank; Pföhler, Claudia; Kreuter, Alexander; Herbst, Rudolf; Weichenthal, Michael; Zimmer, Lisa; Meier, Friedegund; Rauschenberg, Ricarda; Mohr, Peter; Brunnert, Fiona; von Wasielewski, Imke; Gutzmer, Ralf; Schadendorf, Dirk ORCID: https://orcid.org/0000-0003-3524-7858; Berking, Carola ORCID: https://orcid.org/0000-0003-0229-8931; Ugurel, Selma und Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643
(22. März 2025):
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma.
In: Journal of the European Academy of Dermatology and Venereology, Bd. 39, Nr. 11: S. 1975-1986
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-0036-072X; Livingstone, Elisabeth; Loquai, Carmen; Kaatz, Martin; Leiter, Ulrike ORCID: https://orcid.org/0000-0002-8019-1577; Schilling, Bastian ORCID: https://orcid.org/0000-0001-8859-4103; Terheyden, Patrick; Hassel, Jessica; Sachse, Michael; Ulrich, Jens; Dippel, Edgar; Meiss, Frank; Pföhler, Claudia; Kreuter, Alexander; Herbst, Rudolf; Weichenthal, Michael; Zimmer, Lisa; Meier, Friedegund; Rauschenberg, Ricarda; Mohr, Peter; Brunnert, Fiona; von Wasielewski, Imke; Gutzmer, Ralf; Schadendorf, Dirk ORCID: https://orcid.org/0000-0003-3524-7858; Berking, Carola ORCID: https://orcid.org/0000-0003-0229-8931; Ugurel, Selma und Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643
(22. März 2025):
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma.
In: Journal of the European Academy of Dermatology and Venereology, Bd. 39, Nr. 11: S. 1975-1986
[PDF, 1MB]
DeTemple, Viola K. ORCID: https://orcid.org/0000-0001-6246-8862; Kaatz, Martin ORCID: https://orcid.org/0000-0002-0650-2576; Stockfleth, Eggert; Scheel, Christina; Angela, Yenny ORCID: https://orcid.org/0000-0002-6643-7286; Gutzmer, Ralf ORCID: https://orcid.org/0000-0001-7921-2820; Leiter, Ulrike; Meier, Friedegund ORCID: https://orcid.org/0000-0003-4340-9706; Schadendorf, Dirk ORCID: https://orcid.org/0000-0003-3524-7858; Livingstone, Elisabeth ORCID: https://orcid.org/0000-0001-8279-9239; Gebhardt, Christoffer ORCID: https://orcid.org/0000-0001-7090-9584; Wasielewski, Imke von; Weichenthal, Michael ORCID: https://orcid.org/0000-0002-9060-4961; Mohr, Peter; Hassel, Jessica ORCID: https://orcid.org/0000-0001-7575-6230; Pföhler, Claudia ORCID: https://orcid.org/0000-0003-0384-114X; Simon, Jan Christoph; Jochims, Franziska ORCID: https://orcid.org/0000-0003-2279-2072; Terheyden, Patrick; Ulrich, Jens; Haferkamp, Sebastian; Drexler, Konstantin; Schilling, Bastian; Glutsch, Valerie ORCID: https://orcid.org/0000-0001-9291-1327; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643; Berking, Carola; Ugurel, Selma ORCID: https://orcid.org/0000-0002-9384-6704 und Tomsitz, Dirk ORCID: https://orcid.org/0000-0003-0036-072X
(2025):
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma.
In: European Journal of Cancer, Bd. 225, 115590
[PDF, 2MB]
ORCID: https://orcid.org/0000-0001-6246-8862; Kaatz, Martin ORCID: https://orcid.org/0000-0002-0650-2576; Stockfleth, Eggert; Scheel, Christina; Angela, Yenny ORCID: https://orcid.org/0000-0002-6643-7286; Gutzmer, Ralf ORCID: https://orcid.org/0000-0001-7921-2820; Leiter, Ulrike; Meier, Friedegund ORCID: https://orcid.org/0000-0003-4340-9706; Schadendorf, Dirk ORCID: https://orcid.org/0000-0003-3524-7858; Livingstone, Elisabeth ORCID: https://orcid.org/0000-0001-8279-9239; Gebhardt, Christoffer ORCID: https://orcid.org/0000-0001-7090-9584; Wasielewski, Imke von; Weichenthal, Michael ORCID: https://orcid.org/0000-0002-9060-4961; Mohr, Peter; Hassel, Jessica ORCID: https://orcid.org/0000-0001-7575-6230; Pföhler, Claudia ORCID: https://orcid.org/0000-0003-0384-114X; Simon, Jan Christoph; Jochims, Franziska ORCID: https://orcid.org/0000-0003-2279-2072; Terheyden, Patrick; Ulrich, Jens; Haferkamp, Sebastian; Drexler, Konstantin; Schilling, Bastian; Glutsch, Valerie ORCID: https://orcid.org/0000-0001-9291-1327; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643; Berking, Carola; Ugurel, Selma ORCID: https://orcid.org/0000-0002-9384-6704 und Tomsitz, Dirk ORCID: https://orcid.org/0000-0003-0036-072X
(2025):
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma.
In: European Journal of Cancer, Bd. 225, 115590
[PDF, 2MB]
Franklin, Cindy ORCID: https://orcid.org/0000-0001-9142-5423; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael ORCID: https://orcid.org/0000-0002-9060-4961; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick ORCID: https://orcid.org/0000-0002-5894-1677; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebastian; Kaatz, Martin; Forschner, Andrea ORCID: https://orcid.org/0000-0002-6185-4945; Leiter, Ulrike; Nashan, Dorothee; Kreuter, Alexander ORCID: https://orcid.org/0000-0003-2275-499X; Sachse, Michael; Welzel, Julia; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643; Meiss, Frank; Weishaupt, Carsten; Gambichler, Thilo ORCID: https://orcid.org/0000-0001-7862-3695; Weyandt, Gerhard; Dippel, Edgar; Schatton, Kerstin; Celik, Eren; Trommer, Maike ORCID: https://orcid.org/0000-0003-2864-4273; Helfrich, Iris; Roesch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, Susanne und Ugurel, Selma ORCID: https://orcid.org/0000-0002-9384-6704
(2022):
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, Nr. 6, e004509
ORCID: https://orcid.org/0000-0001-9142-5423; Mohr, Peter; Bluhm, Leonie; Grimmelmann, Imke; Gutzmer, Ralf; Meier, Friedegund; Garzarolli, Marlene; Weichenthal, Michael ORCID: https://orcid.org/0000-0002-9060-4961; Pfoehler, Claudia; Herbst, Rudolf; Terheyden, Patrick ORCID: https://orcid.org/0000-0002-5894-1677; Utikal, Jochen; Ulrich, Jens; Debus, Dirk; Haferkamp, Sebastian; Kaatz, Martin; Forschner, Andrea ORCID: https://orcid.org/0000-0002-6185-4945; Leiter, Ulrike; Nashan, Dorothee; Kreuter, Alexander ORCID: https://orcid.org/0000-0003-2275-499X; Sachse, Michael; Welzel, Julia; Heinzerling, Lucie ORCID: https://orcid.org/0000-0001-5718-3643; Meiss, Frank; Weishaupt, Carsten; Gambichler, Thilo ORCID: https://orcid.org/0000-0001-7862-3695; Weyandt, Gerhard; Dippel, Edgar; Schatton, Kerstin; Celik, Eren; Trommer, Maike ORCID: https://orcid.org/0000-0003-2864-4273; Helfrich, Iris; Roesch, Alexander; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Horn, Susanne und Ugurel, Selma ORCID: https://orcid.org/0000-0002-9384-6704
(2022):
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, Nr. 6, e004509
Koch, Elias A. T.; Petzold, Anne; Wessely, Anja; Dippel, Edgar; Gesierich, Anja; Gutzmer, Ralf; Hassel, Jessica C.; Haferkamp, Sebastian; Kähler, Katharina C.; Knorr, Harald; Kreuzberg, Nicole; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Meissner, Markus; Mohr, Peter; Pfoehler, Claudia; Rahimi, Farnaz; Schadendorf, Dirk; Schell, Beatrice; Schlaak, Max; Terheyden, Patrick; Thoms, Kai-Martin; Schuler-Thurner, Beatrice; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weichenthal, Michael; Ziller, Fabian; Berking, Carola und Heppt, Markus V.
(2022):
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity.
In: Cancers, Bd. 14, Nr. 3, 518
Koch, Elias A. T.; Petzold, Anne; Wessely, Anja; Dippel, Edgar; Gesierich, Anja; Gutzmer, Ralf; Hassel, Jessica C.; Haferkamp, Sebastian; Hohberger, Bettina; Kaehler, Katharina C.; Knorr, Harald; Kreuzberg, Nicole; Leiter, Ulrike; Loquai, Carmen; Meier, Friedegund; Meissner, Markus; Mohr, Peter; Pfoehler, Claudia; Rahimi, Farnaz; Schadendorf, Dirk; Schell, Beatrice; Schlaak, Max; Terheyden, Patrick; Thoms, Kai-Martin; Schuler-Thurner, Beatrice; Ugurel, Selma; Ulrich, Jens; Utikal, Jochen; Weichenthal, Michael; Ziller, Fabian; Berking, Carola und Heppt, Markus V.
(2021):
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis.
In: Cancers, Bd. 13, Nr. 13, 3359
Knispel, Sarah; Stang, Andreas; Zimmer, Lisa; Lax, Hildegard; Gutzmer, Ralf; Heinzerling, Lucie; Weishaupt, Carsten; Pfoehler, Claudia; Gesierich, Anja; Herbst, Rudolf; Kaehler, Katharina C.; Weide, Benjamin; Berking, Carola; Loquai, Carmen; Utikal, Jochen; Terheyden, Patrick; Kaatz, Martin; Schlaak, Max; Kreuter, Alexander; Ulrich, Jens; Mohr, Peter; Dippel, Edgar; Livingstone, Elisabeth; Becker, Jürgen C.; Weichenthal, Michael; Chorti, Eleftheria; Gronewold, Janine; Schadendorf, Dirk und Ugurel, Selma
(2020):
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.
In: Journal for Immunotherapy of Cancer, Bd. 8, Nr. 1, e000395
Leiter, Ulrike; Stadler, Rudolf; Mauch, Cornelia; Hohenberger, Werner; Brockmeyer, Norbert H.; Berking, Carola; Sunderkoetter, Cord; Kaatz, Martin; Schatton, Kerstin; Lehmann, Percy; Vogt, Thomas; Ulrich, Jens; Herbst, Rudolf; Gehring, Wolfgang; Simon, Jan-Christoph; Keim, Ulrike; Verver, Danielle; Martus, Peter und Garbe, Claus
(2019):
Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
In: Journal of Clinical Oncology, Bd. 37, Nr. 32
Leiter, Ulrike; Stadler, Rudolf; Mauch, Cornelia; Hohenberger, Werner; Brockmeyer, Norbert; Berking, Carola; Sunderkötter, Cord; Kaatz, Martin; Schulte, Klaus-Werner; Lehmann, Percy; Vogt, Thomas; Ulrich, Jens; Herbst, Rudolf; Gehring, Wolfgang; Simon, Jan-Christoph; Keim, Ulrike; Martus, Peter und Garbe, Claus
(2016):
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 17, Nr. 6: S. 757-767
Heppt, Markus V.; Eigentler, Thomas K.; Kähler, Katharina C.; Herbst, Rudolf A.; Göppner, Daniela; Gambichler, Thilo; Ulrich, Jens; Dippel, Edgar; Loquai, Carmen; Schell, Beatrice; Schilling, Bastian; Schäd, Susanne G.; Schultz, Erwin S.; Matheis, Fanny; Tietze, Julia K. und Berking, Carola
(2016):
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis.
In: Cancer Immunology Immunotherapy, Bd. 65, Nr. 8: S. 951-959
Voskens, Caroline J.; Goldinger, Simone M.; Loquai, Carmen; Robert, Caroline; Kaehler, Katharina C.; Berking, Carola; Bergmann, Tanja; Bockmeyer, Clemens L.; Eigentler, Thomas; Fluck, Michael; Garbe, Claus; Gutzmer, Ralf; Grabbe, Stephan; Hauschild, Axel; Hein, Rüdiger; Hundorfean, Gheorghe; Justich, Armin; Keller, Ullrich; Klein, Christina; Mateus, Christine; Mohr, Peter; Paetzold, Sylvie; Satzger, Imke; Schadendorf, Dirk; Schlaeppi, Marc; Schuler, Gerold; Schuler-Thurner, Beatrice; Trefzer, Uwe; Ulrich, Jens; Vaubel, Julia; Moos, Roger von; Weder, Patrik; Wilhelm, Tabea; Göppner, Daniela; Dummer, Reinhard und Heinzerling, Lucie M.
(2013):
The price of tumor control. An analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network.
In: PLOS ONE 8(1), e53745 [PDF, 5MB]
In: PLOS ONE 8(1), e53745 [PDF, 5MB]